Raffles Medical Group (FRA:02M1) Moat Score: 6/10 (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:02M1 Raffles Medical Group Ltd FRA:02M1
86 GF Score
Price €0.63
GF Value €0.70
! 4 Warning Signs
View Full Analysis

What is Raffles Medical Group Moat Score?

Raffles Medical Group FRA:02M1 +0.80% 86 Moat Score is 6 as of Jul. 17, 2026. GuruFocus rates FRA:02M1 with a GF Score™ of 86/100 and a GF Value™ of €0.70. The stock has 4 warning signs investors should review. Among 675 Healthcare Providers & Services companies, Raffles Medical Group ranks better than 99.11% on this metric.

Raffles Medical Group has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Raffles Medical Group has Narrow Moat: Raffles Medical Group Ltd has a strong narrow moat due to its established brand and market presence in healthcare services. It benefits from regulatory barriers and customer loyalty, but faces competition that limits its pricing power and innovation capabilities.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Raffles Medical Group might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Raffles Medical Group  (FRA:02M1) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Raffles Medical Group Moat Score Related Terms

FRA:02M1 vs HCA, THC, DVA: Moat Score Comparison

For the Medical Care Facilities subindustry, Raffles Medical Group's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raffles Medical Group Moat Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raffles Medical Group's Moat Score distribution charts can be found below:

* The bar in red indicates where Raffles Medical Group's Moat Score falls into.


FRA:02M1
86GF Score
Raffles Medical Group Ltd FRA:02M1
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Raffles Medical Group (FRA:02M1) has a Moat Score of 6 as of Jul. 17, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Raffles Medical Group ranks #6 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 0.90000000000001%.
Is Raffles Medical Group's Moat Score too high?
Raffles Medical Group's current Moat Score is 6. Based on the distribution chart, Raffles Medical Group ranks #6 out of 675 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Raffles Medical Group has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Raffles Medical Group's Moat Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raffles Medical Group ranks #6 out of 675 companies for Moat Score. This places Raffles Medical Group in the top 1% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Healthcare Providers & Services company?
A good Moat Score depends on the Healthcare Providers & Services industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Raffles Medical Group's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raffles Medical Group stock overvalued right now?
Raffles Medical Group (FRA:02M1) has a current Moat Score of 6. The stock's GF Value™ is €0.70, compared to a current price of €0.63 — trading 10% below its estimated fair value. The current Moat Score is 6. Raffles Medical Group's overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Raffles Medical Group (FRA:02M1), the current Moat Score is 6 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raffles Medical Group (FRA:02M1) Overvalued in 2026?

Based on GuruFocus' analysis, Raffles Medical Group stock appears to be undervalued. The current stock price of €0.63 is trading 10% below its estimated GF Value™ of €0.70.

Key valuation signals for FRA:02M1:

  • Moat Score: 6
  • GF Value™: €0.70 vs. price of €0.63 (10% below fair value)
  • GF Score™: 86/100 with 4 warning signs

No single metric tells the full story. See the FRA:02M1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raffles Medical Group Business Description

Other Exchanges BSL:Singapore
Address 585 North Bridge Road, No. 11-00, Raffles Hospital, Singapore, SGP, 188770
Raffles Medical Group Ltd is an integrated private healthcare provider in Asia with operations in Singapore, China, Japan, Vietnam, and Cambodia. The company owns and operates a tertiary hospital, a network of medical and dental clinics, insurance services, Japanese and Traditional Chinese Medicine clinics, and a consumer healthcare division. The company's operating segment includes Healthcare services, Hospital Services, Investment Holdings, and Insurance Services. The company generates revenue from contracts with customers, Rental Income, and Insurance revenue. Geographically operates in Singapore, Greater China, Vietnam, Cambodia and Japan.
86GF Score

Get the complete analysis for FRA:02M1

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.63
Price
€0.70
GF Value